GlassScriptPhysician profile
Heather A Lewis
NPI 1376686030
$1,360.59
in general payments reported to CMS, 2019-2025
22 companies · $531 in 2025
The $531 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $42.51 · 2022: $171 · 2023: $179 · 2024: $271 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.88 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $377.15 | 2019-2025 | Veozah |
| Aspira Women'S Health INC | $166.16 | 2022-2023 | Ova1 |
| Abbvie INC. | $157.20 | 2019-2025 | |
| Biogen, INC. | $111.04 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $84.10 | 2024-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $77.46 | 2024-2025 | Novasure, Acessa Provu System, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $52.75 | 2019-2022 | |
| Exeltis, USA INC. | $45.49 | 2023-2025 | Slynd |
| Pfizer INC. | $37.97 | 2022-2023 | |
| Myovant Sciences INC. | $32.17 | 2022 | |
| Coopersurgical, INC. | $29.16 | 2019 | |
| Organon LLC | $22.88 | 2022-2025 | Jada System |
| Merck Sharp & Dohme LLC | $21.68 | 2019 | |
| Dynavax Technologies Corporation | $21.39 | 2025 | Heplisav-B |
| Sanofi Pasteur INC. | $21.23 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $18.80 | 2025 | |
| Pharmacosmos Therapeutics INC. | $18.48 | 2025 | Monoferric |
| Pacira Pharmaceuticals Incorporated | $13.93 | 2024 | Exparel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.74 | 2024 | Xifaxan |
| Millicent US INC | $13.74 | 2024 | Intrarosa |
| Amgen INC. | $12.14 | 2019 | |
| Avion Pharmaceuticals | $11.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.